Accredo offers a wide range of medications to treat various complex and chronic conditions. Visit Conditions to learn more about treatment, medications, and support for your condition.
| Medication | Condition(s) | Generic/Biosimilar | Manufacturer |
|---|---|---|---|
| Ebglyss™ (lebrikizumab-lbkz) | Eli Lilly & Co. | ||
| Edurant® (rilpivirine) | Janssen Therapeutics | ||
| Egrifta® (tesamorelin for injection) |
Excess abdominal fat
|
Theratechnologies, Inc. | |
| Ekterly® | KalVista | ||
| Elaprase® (idursulfase) | Takeda Pharmaceuticals | ||
| Elelyso® (taliglucerase alfa) | Pfizer, Inc. | ||
| Elevidys® (delandistrogene moxeparvovec-rokl) | Sarepta Therapeutics | ||
| Elfabrio® (pegunigalsidase alfa-iwxj) | CHIESI FARMACEUTICI S.p.A. | ||
| Eligard® (leuprolide acetate) |
Prostate cancer
|
Tolmar Pharmaceuticals, Inc. | |
| Eloctate™ (anitemophilic factor [recombinant], fc fusion protein) | Bioverativ |